2010 - Review: Treatment for gestational diabetes reduces risk for shoulder dystocia

Guinn, Debra A.
September 2010
ACP Journal Club;9/21/2010, Vol. 153 Issue 3, p5
Academic Journal
The article presents a study establishing whether treatment for gestational diabetes mellitus (GDM) reduce perinatal or maternal complications in pregnant women. According to random control tests (RCTs) and meta-analysis by K. Horvath and colleagues, treatment for gestational diabetes reduces risk for shoulder dystocia only while other patient-relevant perinatal or maternal outcomes remain unaffected. A comparison chart depicting outcomes for treatment and usual care in GMD, is also presented.


Related Articles

  • Delivering a shoulder dystocia: how I do it. Chez, Ronald A.; Clark, Steven L. // Contemporary OB/GYN;Oct99, Vol. 44 Issue 10, p66 

    Describes the approach of Doctor Steven Clark, an expert on high risk pregnancy, in delivering a patient with shoulder dystocia. Definition of shoulder dystocia; Surgical procedures; Postdelivery examination.

  • Comparison of Glyburide with Metformin in Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Amin, Muhammad; Suksomboon, Naeti; Poolsup, Nalinee; Malik, Obaidullah // Clinical Drug Investigation;Jun2015, Vol. 35 Issue 6, p343 

    Background and Objective: Controversy has surrounded the treatment of gestational diabetes mellitus (GDM) for a long time. Although the use of both glyburide and metformin are recommended as an alternate to insulin if dietary therapy fails in GDM patients, it remains unclear whether both drugs...

  • Cerebral Palsy and Cut Cords. J. D. // Midwifery Matters;Winter2004, Issue 103, p37 

    Presents cases of cerebral palsy during pregnancy. Delay of birth; Detection of dystocia; Implication of cutting the nuchal cord.

  • The Use of Meta-Analysis in Cost-Effectiveness Analysis: Issues and Recommendations. Saint, S.; Veenstra, D.L.; Sullivan, S.D. // PharmacoEconomics;1999, Vol. 15 Issue 1, p1 

    Meta-analysis is used to statistically pool the results from individual studies, usually randomised trials, to obtain an estimate of the summary effect size across studies. The summary measure from a meta-analysis is often used to derive the probability of treatment success in a...

  • Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Kristian Thorlund; P J Devereaux; Jørn Wetterslev; Gordon Guyatt; John P A Ioannidis; Lehana Thabane; Lise-Lotte Gluud; Bodil Als-Nielsen; Christian Gluud // International Journal of Epidemiology;Feb2009, Vol. 38 Issue 1, p276 

    Background Results from apparently conclusive meta-analyses may be false. A limited number of events from a few small trials and the associated random error may be under-recognized sources of spurious findings. The information size (IS, i.e. number of participants) required for a reliable and...

  • Blood Pressure Response to Transcendental Meditation: A Meta-analysis. Anderson, James W.; Chunxu Liu; Kryscio, Richard J. // American Journal of Hypertension;Mar2008, Vol. 21 Issue 3, p310 

    BACKGROUND Prior clinical trials suggest that the Transcendental Meditation technique may decrease blood pressure of normotensive and hypertensive individuals but study-quality issues have been raised. This study was designed to assess effects of Transcendental Meditation on blood pressure using...

  • Why we need a broad perspective on meta-analysis. Gotzsche, Peter C // BMJ: British Medical Journal (International Edition);09/09/2000, Vol. 321 Issue 7261, p585 

    Editorial. Discusses factors affecting the usefulness of meta-analyses and clinical trials in medical research. Examples of the potential adverse health effects resulting from the narrow interpretation of meta-analysis results; Advantages of broad approaches to meta-analyses.

  • Meta-Analysis of Multi-Arm Trials Using Empirical Logistic Transform. Chootrakool, Hathaikan; Jian Qing Shi // Open Medical Informatics Journal;2008, Vol. 2, p112 

    Meta-analysis of multi-arm trials has been used increasingly in recent years. The aim of meta-analysis for multi-arm trials is to combine evidence from all possible similar studies. In this paper we propose normal approximation models by using empirical logistic transform to compare different...

  • Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses. Thorlund, Kristian; Imberger, Georgina; Johnston, Bradley C.; Walsh, Michael; Awad, Tahany; Thabane, Lehana; Gluud, Christian; Devereaux, P. J.; Wetterslev, Jørn // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Background: Assessment of heterogeneity is essential in systematic reviews and meta-analyses of clinical trials. The most commonly used heterogeneity measure, I2, provides an estimate of the proportion of variability in a meta-analysis that is explained by differences between the included trials...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics